The role and limitations of radio-frequency ablation in treatment of bone and soft tissue tumors

被引：15

作者：

Ahrar K. ^{[1
]}

机构：

[1] Section of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas, Houston, TX 77030

来源：

Current Oncology Reports | 2004年 / 6卷 / 4期

关键词：

Radiofrequency Ablation; Soft Tissue Tumor; Osteoid Osteoma; Osseous Metastasis; Percutaneous Radiofrequency Ablation;

D O I：

10.1007/s11912-004-0042-1

中图分类号：

学科分类号：

摘要：

Percutaneous radiofrequency ablation (RFA) has evolved as an alternative therapy for treatment of certain patients with liver tumors. This novel image-guided intervention is a minimally invasive form of therapy with negligible morbidity. RFA has also been used for treatment of selected patients with renal and lung malignancies who may not be suitable surgical candidates. With the exception of osteoid osteomas, surgical management remains the treatment of choice for primary bone and soft tissue tumors. The role of RFA in definitive treatment of sarcomas has not been investigated. However, RFA has replaced surgery for treatment of osteoid osteomas and can play a role in palliation of painful bone and soft tissue tumors. Copyright © 2004 by Current Science Inc.

引用

页码：315 / 320

页数：5

共 27 条

[1]

Nahum Goldberg S., Dupuy D.E., Image-guided radiofrequency tumor ablation: Challenges and opportunities: Part I, J. Vasc. Interv. Radiol., 12, pp. 1021-1032, (2001)

[2]

Dupuy D.E., Goldberg S.N., Image-guided radiofrequency tumor ablation: Challenges and opportunities: Part II, J. Vasc. Interv. Radiol., 12, pp. 1135-1148, (2001)

[3]

Callstrom M.R., Charboneau J.W., Goetz M.P., Et al., Painful metastases involving bone: Feasibility of percutaneous CT- and US-guided radio-frequency ablation, Radiology, 224, pp. 87-97, (2002)

[4]

Jain S.K., Dupuy D.E., Cardarelli G.A., Et al., Percutaneous radiofrequency ablation of pulmonary malignancies: Combined treatment with brachytherapy, AJR Am. J. Roentgenol., 181, pp. 711-715, (2003)

[5]

Curley S.A., Izzo F., Delrio P., Ellis L.M., Et al., Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients, Ann. Surg., 230, pp. 1-8, (1999)

[6]

Goldberg S.N., Gazelle G.S., Compton C.C., Et al., Treatment of intrahepatic malignancy with radiofrequency ablation: Radiologic-pathologic correlation, Cancer, 88, pp. 2452-2463, (2000)

[7]

Curley S.A., Izzo F., Ellis L.M., Et al., Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis, Ann. Surg., 232, pp. 381-391, (2000)

[8]

Dromain C., de Baere T., Elias D., Et al., Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up, Radiology, 223, pp. 255-262, (2002)

[9]

Gervais D.A., McGovern F.J., Arellano R.S., Et al., Renal cell carcinoma: Clinical experience and technical success with radiofrequency ablation of 42 tumors, Radiology, 226, pp. 417-424, (2003)

[10]

Lee J.M., Jin G.Y., Goldberg S.N., Et al., Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: Preliminary report, Radiology, 230, pp. 125-134, (2004)

← 1 2 3 →